Furthermore, inhibition of uPAR and cathepsin B in glioma stem cells was associated with decreased expression of SOX2 and Bmi1, suggesting that cathepsin B and uPAR have pivotal roles in maintaining the malignant nature of CSCs in gliomas (36). Here, BMI1 is linked to glioma.